SCHEMBL8538491

SCHEMBL8538491

Cc1ccc(C(O)CCCCCBr)c(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 1/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.33
▸ MAPT P10636 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ OPRM1 P35372 1/20 0.33
▸ OPRL1 P41146 1/20 0.33
▸ TRPA1 O75762 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ CHRM1 P11229 1/20 0.33
▸ SLC6A2 P23975 1/20 0.33
▸ ADRA1A P35348 1/20 0.33
▸ HTR2B P41595 1/20 0.33
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ ADRA2C P18825 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ PDE2A O00408 1/20 0.31
▸ SRC P12931 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7787266 0.82 LMNA (0.37) NPSR1MAPTRAB9AATML3MBTL1
SCHEMBL8537573 0.81 ADRA2A (0.40) ADRA1AADRB2ADRB1
SCHEMBL8540416 0.74 TBXAS1 (0.42) —
SCHEMBL9258888 0.74 MEN1 (0.59) CYP1A2CYP2C19ADRA2CTP53
SCHEMBL20103677 0.72 ADRA2A (0.45) MAPTADRA1ACYP1A2ADRA2CADRB2
SCHEMBL11552416 0.72 ACLY (0.40) —
SCHEMBL18448342 0.70 PDE2A (0.56) NPSR1MAPTRAB9AATML3MBTL1
SCHEMBL19205736 0.70 PDE2A (0.56) NPSR1MAPTRAB9AATML3MBTL1
SCHEMBL23347585 0.69 MAPT (0.36) PDE5ANPSR1MAPTRAB9AATM
SCHEMBL16072188 0.69 MAPT (0.36) PDE5ANPSR1MAPTRAB9AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5750532-A TETRAHYDROPYRIMIDINE-2,4-DIONE DERIVATIVES, VIRICIDES, ANTIINFLAMMATORY AGENTS, PAF INHIBITORS SCHERING CORPORATION (US) 1998-05-12 — — US disclosed
EP-0274867-A2 Pharmaceutically active compounds SCHERING CORPORATION (US) 1988-07-20 — — EP disclosed
Send feedback